Clinical Trials Logo

Filter by:
NCT ID: NCT03980730 Terminated - Alzheimer Disease Clinical Trials

Study of Azeliragon in Patients With Mild Alzheimer's Disease and Impaired Glucose Tolerance

Elevage
Start date: June 27, 2019
Phase: Phase 2
Study type: Interventional

This is a study to evaluate the efficacy and safety of azeliragon in patients with mild Alzheimer's disease and impaired glucose tolerance. Patients will receive either azeliragon or placebo with a patient's participation lasting approximately 9 months (in Part 1) or 21 months (in Part 2).

NCT ID: NCT03980366 Terminated - Clinical trials for Autism Spectrum Disorder

Use of Electroconvulsive Therapy to Treat Self-Injurious Behavior in Adults With Autism Spectrum Disorders

Start date: March 15, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to use formal measures to monitor the outcome of using electroconvulsive therapy to treat self-injurious behavior in adults with Autism Spectrum Disorder for whom psychotropic medication has not worked. This study will be fundamentally different from the previously published literature on the subject in that this will be a prospective study which will aim to recruit multiple participants in an open label study.

NCT ID: NCT03980262 Terminated - Obesity Clinical Trials

Church, Extension and Academic Partners Empowering Healthy Families

EHF
Start date: February 19, 2019
Phase: N/A
Study type: Interventional

The project will address health disparities via a community-engaged approach in partnership with black churches. The long-term goals of this integrated project are to: 1) prevent and reduce childhood obesity through improved parenting practices and home environment related to obesity; 2) expand Extension capacity for community-engaged research and collaborative programming with faith-based organizations; 3) enhance Extension strategies for recruiting and training community volunteers to extend Extension reach; and 4) train future health professionals to provide culturally appropriate collaborative community-based health programs. The project will target the school-aged subset (ages 6-11, first through fifth grade) of the USDA target age range of ages 2-19. The 14-month randomized control trial design of the research component will generate new knowledge regarding effectiveness of a integrated family-based intervention enhanced with social and environmental (church) support to prevent obesity in school-aged children. The research design with a financial literacy active control condition and the primary nutrition and physical activity intervention being tested meets two needs expressed by the community partner and allows rigorous evaluation of both Extension programs. It is hypothesized that parents in the intervention group will have higher levels of self-efficacy for obesity-prevention behaviors, parenting practices related to food and physical activity, improved home food and physical activity. The long term impact is to reduce the prevalence of childhood obesity.

NCT ID: NCT03980236 Terminated - Clinical trials for Type 2 Diabetes Treated With Insulin

Feasibility of Using the Livongo-Insulia Study App for Patients With Type 2 Diabetes [Pilot Study]

LISA Pilot
Start date: May 6, 2019
Phase: N/A
Study type: Interventional

The Livongo-Insulia Study App Pilot Study (LISA Pilot) is a 3-month, prospective, interventional study. The purpose of this pilot study is to evaluate the feasibility of using the Livongo-Insulia Study App for individuals with type 2 diabetes using basal insulin. This will be assessed by measuring the impact of the Livongo-Insulia Study App on glycemic control for these individuals.

NCT ID: NCT03979638 Terminated - Clinical trials for Chronic Refractory Cough

A Dose Escalation Study of BLU-5937 in Unexplained or Refractory Chronic Cough

RELIEF
Start date: July 10, 2019
Phase: Phase 2
Study type: Interventional

This is a multi-center, randomized, double-blind, placebo-controlled, crossover, dose escalation study of BLU-5937 in subjects with unexplained or refractory chronic cough

NCT ID: NCT03979547 Terminated - Clinical trials for Hepatocellular Carcinoma

EXALT: EXercise Attenuates Liver Tumors Trial

EXALT
Start date: January 3, 2019
Phase: N/A
Study type: Interventional

The overall goal of this proposal is to test the effect of exercise to delay or avert HCC recurrence and gain information regarding the potential molecular mechanisms of HCC tumor inhibition by exercise.

NCT ID: NCT03979066 Terminated - Clinical trials for Pancreatic Ductal Adenocarcinoma

Study Evaluating NEOadjuvant Immunotherapy in Resectable PANCreatic Ductal Adenocarcinoma

NEOiPANC
Start date: November 1, 2019
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine if study treatment with atezolizumab and PEGPH20 given before and after surgery, followed by chemotherapy is safe and if it can further increase the immune response against the tumor rather than increase the chance of cure.

NCT ID: NCT03978637 Terminated - Clinical trials for Bronchiolitis Obliterans Syndrome

Safety and Efficacy of Itacitinib in Participants With Bronchiolitis Obliterans Syndrome Following Lung Transplantation

Start date: February 4, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety, efficacy, pharmacokinetics, and pharmacodynamics of itacitinib in participants with post-lung transplant bronchiolitis obliterans syndrome (BOS).

NCT ID: NCT03978416 Terminated - Obesity Clinical Trials

Development of Novel Behavioral Intervention for Sustainable Weight Loss in Hispanic Adults With Obesity

Start date: August 23, 2019
Phase: N/A
Study type: Interventional

There are great disparities in the prevalence of obesity and chronic disease in different sociodemographic groups. US Hispanic adults, in particular, have a higher prevalence of obesity and chronic diseases than non-Hispanic whites. Population aging is also a major contributing factor to the high prevalence of chronic disease, and Hispanics already make up approximately 10% of the older population. Therefore, preventive measures are needed to reduce the burden of chronic disease risks for Hispanics. Current lifestyle interventions for weight management have been particularly ineffective in this population. The purpose of this pilot project is to develop a novel tailored lifestyle intervention for use by Hispanic older adults with obesity. The Healthy Weight for Living intervention has been validated among adults with mixed racial/ethnic backgrounds and has achieved clinically impactful weight-loss. Its design features make it particularly suitable for use in populations with low adherence to traditional interventions, including no requirement for daily food logging and no increase in physical activity. The final product of this project will be a culturally adapted prototype intervention in Hispanic older adults that accounts for cultural heterogeneity. This work has direct relevance to reducing health disparities and the burden of obesity-associated chronic disease in a particularly at-risk population.

NCT ID: NCT03978156 Terminated - Sickle Cell Disease Clinical Trials

Dronabinol for Pain and Inflammation in Adults Living With Sickle Cell Disease

Start date: July 26, 2019
Phase: Phase 1
Study type: Interventional

This study is designed to address the feasibility of a randomized, double masked, cross-over study of dronabinol as a palliative agent in the treatment of pain, inflammation, and other complications of sickle cell disease (SCD).